Asunercept as an innovative therapeutic approach for recurrent glioblastoma and other malignancies
Andriy Krendyukov, Christian GieffersApogenix AG, Heidelberg, GermanyCorrespondence: Andriy KrendyukovApogenix AG, Im Neuenheimer Feld 584, Heidelberg 69120, GermanyEmail andriy.krendyukov@apogenix.comAbstract: Glioblastoma is the most common and ...
Krendyukov A, Gieffers C
doaj
Metabolic quiescence of naive-like memory T cells precedes and maintains antigen-specific T cell memory. [PDF]
Frischholz S +23 more
europepmc +1 more source
Semisynthetic Ferritin Nanocages for Flexible, Site-Specific Targeting and Ligand-Free Activation of Membrane Receptors. [PDF]
Neusch A +4 more
europepmc +1 more source
Peripheral immune landscape in pancreatic ductal adenocarcinoma reveals expansion of effector states with disease progression. [PDF]
Yang CH +8 more
europepmc +1 more source
Pre-existing CD95-based Temra immunity in patients with recurrent/metastatic nasopharyngeal carcinoma predicts response and hyperprogression to dual PD-L1 and TGFβ inhibition. [PDF]
Kam NW +8 more
europepmc +1 more source
Peripheral blood immune cell subsets as non-invasive biomarkers of colorectal cancer stage, laterality, metastasis and survival. [PDF]
Del Prado-Montero J +14 more
europepmc +1 more source
Correction: Inhibitor of Apoptosis-Stimulating Protein of p53 (iASPP) Is Required for Neuronal Survival after Axonal Injury. [PDF]
Wilson AM +5 more
europepmc +1 more source
Decidual CD4 Effector Memory and Resident Memory T Cells Respond to Cord Blood Allo-Antigens. [PDF]
Koenig ZT +7 more
europepmc +1 more source
Curbing Autoimmunity: A New Fab Fragment Targeting CD40-CD40L Halts B-Cell Activation and Differentiation. [PDF]
Pedersen K +13 more
europepmc +1 more source

